A recent update of pharmacogenomics in drug-induced severe skin reactions

Chun Yu Wei, Tai-Ming Ko, Chen Yang Shen*, Yuan Tsong Chen

*此作品的通信作者

研究成果: Review article同行評審

45 引文 斯高帕斯(Scopus)

摘要

Summary: In some adverse drug reactions (ADRs), genetic predisposition plays a significant role in pathogenesis, and the skin is the most frequently reported target. These severe cutaneous ADRs include bullous fixed drug eruptions (FDE), acute generalized exanthematous pustulosis (AGEP), drug-induced hypersensitivity syndrome (HSS), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). The putative contribution of individual effector cells in drug hypersensitivity is briefly mentioned. To trigger these drug hypersensitivities, certain class I HLA alleles (e.g., HLA-A and HLA-B alleles) and certain class II HLA alleles (e.g., HLA-DR alleles) have been recently found to be the genetic determinants. One of the best characterized examples mentioned in this article is HLA-B*1502 to determine the incidence of carbamazepine-induced SJS. How drugs are processed and presented by these HLA alleles to activate immune responses has been explained by several hypotheses. Further implication of pharmagenomic findings to prevent drug-induced severe skin reactions can be achieved by pre-screening putative risk HLA alleles before using drugs.

原文English
頁(從 - 到)132-141
頁數10
期刊Drug Metabolism and Pharmacokinetics
27
發行號1
DOIs
出版狀態Published - 2012

指紋

深入研究「A recent update of pharmacogenomics in drug-induced severe skin reactions」主題。共同形成了獨特的指紋。

引用此